MG53/IRS-1 interaction blocker (Korea University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMG53/IRS-1 interaction blocker (Korea University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin receptor substrate 1 modulatorsMitsugumin-53 modulators
TargetsMitsugumin-53Insulin receptor substrate 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorea University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A